Obstetric anesthesia

Effect of metoclopramide on gastric volume and nausea and vomiting in fasted patients undergoing elective cesarean delivery: a randomized clinical equivalence trial

Int J Obstet AnesthPublished Randomised controlled trial

An erratum to this article was published (Int J Obstet Anesth, Nov 2025 ↗)

Authors' conclusion

In appropriately fasted patients, metoclopramide and saline were equivalent in their effect on gastric volume within ± 17 mL, showing metoclopramide administration had minimal effect on gastric volume in this low-risk population.

Study context

Population
Appropriately fasted patients presenting for elective cesarean delivery72 completed
Comparison
IV metoclopramide 10 mg vs saline
Primary endpoint
Pre- to post-treatment change in gastric volume (gastric ultrasound, Perlas and Roukhomovsky methods); equivalence limits ± 17 mL
Follow-up
30 minutes after study medication
Methodological detailssingle-center, placebo-controlled, equivalence
  • Single-center
  • Placebo-controlled
  • Equivalence

Primary result

As reported in the abstract

Median pre- to post-treatment difference in gastric volume, saline vs metoclopramide
Saline vs MetoclopramideMedian difference, mL (95 % CI)P value
Perlas method
−1(−5 to 2)
P = 0.375
Roukhomovsky method
1(−4 to 5)
P = 0.981
Equivalence significant for both methods
P < 0.001

Further findings

Patients at risk for aspiration (gastric volume > 1.5 mL/kg)

No differences between groups

Median gastric volume, Roukhomovsky vs Perlas method

Pre-treatment difference (Roukhomovsky greater)
13 mL, P < 0.001
Post-treatment difference (Roukhomovsky greater)
11 mL, P < 0.001

Original publication

Effect of metoclopramide on gastric volume and nausea and vomiting in fasted patients undergoing elective cesarean delivery: a randomized clinical equivalence trial. Int J Obstet Anesth. Published 14 August 2025. doi:10.1016/j.ijoa.2025.104754

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.